Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financia...(856341 39193023 Read the full s...),Health
Navigation Links
Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results
Date:8/7/2008
,856,341 39,193,023
Read the full story at http://www.prweb.com/releases/million/june_30/prweb1189394.htm
'/>"/>
| Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved |
Related medicine news :
1. Stiefel Laboratories Completes Acquisition of Barrier Therapeutics
2. Nektar Therapeutics Announces Second Quarter 2008 Results
3. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
4. InteKrin Therapeutics Announces $20 Million Series C Financing
5. Transition Therapeutics Announces No Material Change
6. Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8
7. DIA/AAPS Co-Sponsored Conference to Examine the Immunogenicity of Therapeutic Proteins
8. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
9. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
10. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
11. Horizon Therapeutics Names Timothy P. Walbert as President and CEO
Post Your Comments:
Related Image:
 Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results |
Breaking Medicine News(10 mins):Health News:Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting 2Health News:Weight Watchers Declares Quarterly Dividend 2Health News:Most Hospital Patients Don't Know What Meds They're Taking 2Health News:Most Hospital Patients Don't Know What Meds They're Taking 3Health News:NBTY to be Featured on the FOX Business Program FOXBusiness.com LIVE 2Health News:Depression Survey: Implications for Diverse Communities 2
[1] Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting[0] Weight Watchers Declares Quarterly Dividend[0] Most Hospital Patients Don't Know What Meds They're Taking[0] NBTY to be Featured on the FOX Business Program FOXBusiness.com LIVE[0] Depression Survey: Implications for Diverse Communities
Other Medicine News:Health News:ASHG hosts fourth annual DNA Day essay contest, supports genetics education efforts 2Health News:ASHG hosts fourth annual DNA Day essay contest, supports genetics education efforts 3Health News:ASHG hosts fourth annual DNA Day essay contest, supports genetics education efforts 4Health News:ASHG hosts fourth annual DNA Day essay contest, supports genetics education efforts 5Health News:Depression linked with accumulation of visceral fat 2Health News:Study examines radiation dose estimates for pregnant women undergoing therapeutic ERCP 2Health News:Study examines radiation dose estimates for pregnant women undergoing therapeutic ERCP 3Health News:Study examines radiation dose estimates for pregnant women undergoing therapeutic ERCP 4Health News:A Call to Action: NGOs Working in Blindness Prevention and Treatment Convene Special Forum to Address Gender and Eye Health 2Health News:Statement by Christine K. Cassel, MD, President and CEO of the ABIM Foundation on the Institute of Medicine Report: Conflict of Interest in Medical Research, Education, and Practice 2Health News:AIDS Action Applauds Selection of Dr. Eric Goosby as Global AIDS Coordinator 2
ASHG hosts fourth annual DNA Day essay contest, supports genetics education effortsDepression linked with accumulation of visceral fatStudy examines radiation dose estimates for pregnant women undergoing therapeutic ERCPA Call to Action: NGOs Working in Blindness Prevention and Treatment Convene Special Forum to Address Gender and Eye HealthStatement by Christine K. Cassel, MD, President and CEO of the ABIM Foundation on the Institute of Medicine Report: Conflict of Interest in Medical Research, Education, and PracticeAIDS Action Applauds Selection of Dr. Eric Goosby as Global AIDS Coordinator
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 1Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 2Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 3Computers Causing Injuries in the Home 48275 1Computers Causing Injuries in the Home 48275 2Computers Causing Injuries in the Home 48275 3Par Pharmaceutical Begins Shipment of Generic Miacalcin 28R 29 48272 1Par Pharmaceutical Begins Shipment of Generic Miacalcin 28R 29 48272 2
[0] FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology[0] New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals[0] Cambridge Scientists Archive 500,000th Crystal Structure
Other Medicine Technology:Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 2Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 3Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 4NPS Reports Successful GATTEX(TM) Extension Study 2NPS Reports Successful GATTEX(TM) Extension Study 3NPS Reports Successful GATTEX(TM) Extension Study 4NPS Reports Successful GATTEX(TM) Extension Study 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |